Gene Biotherapeutics, Inc. Stock Other OTC
Equities
CRXM
US8767671048
Biotechnology & Medical Research
Financials (USD)
Sales 2019 | - | Sales 2020 | - | Capitalization | 551K |
---|---|---|---|---|---|
Net income 2019 | - | Net income 2020 | - | EV / Sales 2019 | - |
Net Debt 2019 | 1.12M | Net Debt 2020 | 874K | EV / Sales 2020 | - |
P/E ratio 2019 |
3.09
x | P/E ratio 2020 |
-1.77
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 93.84% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 70 | 03-12-21 | |
James Grainer
CHM | Chairman | 69 | 20-05-21 |
Lois Chandler
COO | Chief Operating Officer | - | 10-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 03-12-21 | |
James Grainer
CHM | Chairman | 69 | 20-05-21 |
Ronald Shebuski
CTO | Chief Tech/Sci/R&D Officer | 71 | 20-05-21 |
1st Jan change | Capi. | |
---|---|---|
+2.02% | 42.59B | |
+8.04% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+9.28% | 24.81B | |
-24.48% | 18.17B | |
+28.06% | 12.05B | |
-3.10% | 11.7B | |
+6.85% | 11.1B |